Home
Glaxosmithkline Consumer Healthcare Ltd(merged) Board of Directors
Board of Directors at GlaxoSmithkline Consumer Healthcare Ltd(Merged)
Anup Dhingra
Director (Operation)
Kunal Kashyap
Independent Director
Naresh Dayal
Independent Director
Navneet Saluja
Managing Director
P Dwarakanth
Chairman
Key Highlights
- Kunal Kashyap joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Naresh Dayal joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- P Dwarakanth joins the board as Chairman, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sangeeta Talwar joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shanu Saksena joins the board as Company Secretary, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
GlaxoSmithkline Consumer Healthcare Ltd(Merged)
NSE: GSKCONS
Share Price
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 15 Apr 2020 | 10753.65 | 10500 | 10845.75 | 10394.05 |
| 13 Apr 2020 | 10232.35 | 10700 | 10700 | 10123.85 |
| 09 Apr 2020 | 10365.65 | 10757.7 | 10757.7 | 10152.25 |
| 08 Apr 2020 | 10615.25 | 11109.85 | 11290 | 10500 |
| 07 Apr 2020 | 10590.7 | 9769 | 10666.15 | 9769 |
| 03 Apr 2020 | 9367.15 | 9549 | 9748.35 | 9284 |
| 01 Apr 2020 | 9548.3 | 9993.1 | 10075 | 9435.2 |
| 31 Mar 2020 | 9993.1 | 9596.65 | 10015 | 9522.05 |
| 30 Mar 2020 | 9452.1 | 9250 | 9517.5 | 9203.1 |
| 27 Mar 2020 | 9413.55 | 9759.5 | 9818.85 | 9220 |
| Date |  Price (₹) |
|---|---|
| 15 Apr 2020 | 10753.65 |
| 13 Apr 2020 | 10232.35 |
| 09 Apr 2020 | 10365.65 |
| 08 Apr 2020 | 10615.25 |
| 07 Apr 2020 | 10590.7 |
| 03 Apr 2020 | 9367.15 |
| 01 Apr 2020 | 9548.3 |
| 31 Mar 2020 | 9993.1 |
| 30 Mar 2020 | 9452.1 |
| 27 Mar 2020 | 9413.55 |
Company Fundamentals for GlaxoSmithkline Consumer Healthcare Ltd(Merged)
Market Cap
45,229 Cr
EPS
274.8
P/E Ratio (TTM)
39.1
P/B Ratio (TTM)
10.9
Day’s High
10845.75
Day’s Low
10394.05
DTE
0.0
ROE
26.4
52 Week High
10845.75
52 Week Low
0.0
ROCE
37.9
Market Price of GlaxoSmithkline Consumer Healthcare Ltd(Merged)
1M
1Y
3Y
5Y
Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of GlaxoSmithkline Consumer Healthcare Ltd(Merged)
How are members of GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors selected?
Members of the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors are typically selected based on their expertise, experience, and alignment with GlaxoSmithkline Consumer Healthcare Ltd(Merged)’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors?
Shareholders can interact with the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors meet?
The GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors?
The GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at GlaxoSmithkline Consumer Healthcare Ltd(Merged)?
The current Board of Directors at GlaxoSmithkline Consumer Healthcare Ltd(Merged) includes Kunal Kashyap( Independent Director) ,Naresh Dayal( Independent Director) ,P Dwarakanth( Chairman) ,Sangeeta Talwar( Independent Director) ,Shanu Saksena( Company Secretary) . The full list can be found on GlaxoSmithkline Consumer Healthcare Ltd(Merged)’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.